Organogenesis Hldgs (NASDAQ:ORGO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Organogenesis Hldgs beat estimated earnings by 12.5%, reporting an EPS of $0.09 versus an estimate of $0.08.
Revenue was down $1.79 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 6.33% increase in the share price the next day.
Here’s a look at Organogenesis Hldgs’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.05 | 0.08 | 0.06 | 0.07 |
| EPS Actual | 0.01 | 0.40 | 0.10 | 0.15 |
| Revenue Estimate | 95.93M | 124.70M | 112.67M | 107.30M |
| Revenue Actual | 98.12M | 128.56M | 113.75M | 123.20M |
To track all earnings releases for Organogenesis Hldgs visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
